DaVita Inc. (DVA)
Last updated: 2026-10-20 08:47:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Summary
DaVita Inc. (DVA) operates in the SERVICES-MISC HEALTH & ALLIED SERVICES, NEC sector and is listed on NYSE. The stock is currently priced at $187.06, with a market capitalization of $11.95B and a P/E ratio of 14.08. Over the past 52 weeks, its price has ranged from $101.00 to $247.49. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$11.95B | |
$185.19 | |
$247.49 | |
$10.22 | |
$187.31 | |
239.90K | |
756.33K | |
14.08 | |
$247.49 | |
$101.00 | |
-- | |
-- |
DaVita Inc. (DVA) Pre-Market Stock Price
DaVita Inc. (DVA) is trading at $184.59 in pre-market trading as of 2026-10-19 23:58:00, down 1.45% ($2.72) from the previous close of $187.31
Pre-market trading shows how investors are pricing DVA before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.
DaVita Inc. (DVA) 7-Day Stock Price Change
Over the past seven days, DaVita Inc. (DVA) moved from $179.25 to $187.06, representing a gain of 4.36% ($7.81).
The stock traded between $177.00 and $189.91 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 465.35 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
DVA 52-Week Price Position
Position in Range: 58.7%
DVA is currently trading at $187.06, placing it 58.7% of the way from its 52-week low of $101.00 to its 52-week high of $247.49. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is DaVita Inc. (DVA)?
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
DaVita Inc. Information
| Industry | SERVICES-MISC HEALTH & ALLIED SERVICES, NEC |
| Employees | 78000 |
| Exchange | NYSE |
| Company Website |
How to Buy DaVita Inc. (DVA) Stock on MEXC
Eligible investors can buy real shares of DaVita Inc. (DVA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is DaVita Inc. (DVA) stock price today?
2.Is DVA stock going up or down today?
3.What is DVA pre-market price?
4.What is DVA after-hours price?
5.Is DVA stock trading now?
6.Where does DVA sit relative to its 52-week high and low?
7.What sector is DaVita Inc. in?
8.What is DaVita Inc.'s market capitalization and where is it listed?
9.How is DVA valued in terms of P/E ratio and EPS?
10.Does DaVita Inc. pay a dividend?
Explore More US Stocks
Search Stocks
DVA Stock Calculator
Estimate the value between DVA shares and USD.
DVA Shares to USD
1.00 DVA shares = 187.06 USD
Calculations are estimates based on the latest available price and are for reference only.


